Induction Therapy for Mesothelioma
作者： Isabelle Opitz , Walter Weder
DOI: 10.1053/J.SEMTCVS.2015.05.003
关键词:
摘要: One particular approach of multimodality treatment for mesothelioma is induction therapy followed by surgery. Among its several advantages, the most important downstaging tumor into a resectable stage, although morbidity and mortality might be increased. In this article we review principles outcome different modalities mesothelioma.
semthorcardiovascsurg.com参考文章(64)
Victor A. Levin, Basis and importance of Src as a target in cancer. Cancer treatment and research. ,vol. 119, pp. 89- 119 ,(2004) , 10.1007/1-4020-7847-1_6
E A Rayl, K A Shackelford, L L Habeck, V F Patel, L G Mendelsohn, V J Chen, S B Gates, R M Schultz, M Ratnam, J R Bewley, S L Andis, W C MacKellar, D J Soose, B A Moroson, W Kohler, L S Gossett, G P Beardsley, C Shih, LY231514, a pyrrolo[2,3-d]pyrimidine-based antifolate that inhibits multiple folate-requiring enzymes Cancer Research. ,vol. 57, pp. 1116- 1123 ,(1997)
Gerold Bepler, Ralph G. Zinner, James Moon, Royce Calhoun, Kemp Kernstine, Charles C. Williams, Philip C. Mack, Vasco Oliveira, Zhong Zheng, Philip J. Stella, Mary W. Redman, David R. Gandara, A phase 2 cooperative group adjuvant trial using a biomarker-based decision algorithm in patients with stage I non-small cell lung cancer (SWOG-0720, NCT00792701). Cancer. ,vol. 120, pp. 2343- 2351 ,(2014) , 10.1002/CNCR.28714
Con Manganas, Tristan D. Yan, David Tian, Phoebe Matthews, Christopher Cao, Systematic review of trimodality therapy for patients with malignant pleural mesothelioma. Annals of cardiothoracic surgery. ,vol. 1, pp. 428- 437 ,(2012) , 10.3978/J.ISSN.2225-319X.2012.11.07
David J. Sugarbaker, Michael T. Jaklitsch, Raphael Bueno, William Richards, Jeanne Lukanich, Steven J. Mentzer, Yolonda Colson, Phillip Linden, Michael Chang, Leah Capalbo, Elizabeth Oldread, Siyamek Neragi-Miandoab, Scott J. Swanson, Lambros S. Zellos, Prevention, Early Detection, and Management of Complications After 328 Consecutive Extrapleural Pneumonectomies The Journal of Thoracic and Cardiovascular Surgery. ,vol. 128, pp. 138- 146 ,(2004) , 10.1016/J.JTCVS.2004.02.021
Bryan M. Burt, Robert B. Cameron, Nathan M. Mollberg, Andrzej S. Kosinski, Paul H. Schipper, Joseph B. Shrager, Wickii T. Vigneswaran, Malignant pleural mesothelioma and the Society of Thoracic Surgeons Database: An analysis of surgical morbidity and mortality The Journal of Thoracic and Cardiovascular Surgery. ,vol. 148, pp. 30- 35 ,(2014) , 10.1016/J.JTCVS.2014.03.011
Nina Erčulj, Viljem Kovač, Julija Hmeljak, Alenka Franko, Metoda Dodič-Fikfak, Vita Dolžan, The influence of gemcitabine pathway polymorphisms on treatment outcome in patients with malignant mesothelioma. Pharmacogenetics and Genomics. ,vol. 22, pp. 58- 68 ,(2012) , 10.1097/FPC.0B013E32834E3572
Geoffrey R. Oxnard, Samuel G. Armato, Hedy L. Kindler, Modeling of mesothelioma growth demonstrates weaknesses of current response criteria Lung Cancer. ,vol. 52, pp. 141- 148 ,(2006) , 10.1016/J.LUNGCAN.2005.12.013
Rosalyn B Irby, Timothy J Yeatman, Role of Src expression and activation in human cancer Oncogene. ,vol. 19, pp. 5636- 5642 ,(2000) , 10.1038/SJ.ONC.1203912
Saskia Ting, Fabian D. Mairinger, Thomas Hager, Stefan Welter, Wilfried E. Eberhardt, Jeremias Wohlschlaeger, Kurt W. Schmid, Daniel C. Christoph, ERCC1, MLH1, MSH2, MSH6, and βIII-Tubulin: Resistance Proteins Associated With Response and Outcome to Platinum-based Chemotherapy in Malignant Pleural Mesothelioma Clinical Lung Cancer. ,vol. 14, pp. 558- 567.e3 ,(2013) , 10.1016/J.CLLC.2013.04.013